John Uri Lloyd

From WikiMD's WELLNESSPEDIA

File:John Uri Lloyd.jpg
John Uri Lloyd


John Uri Lloyd (April 19, 1849 – April 9, 1936) was an American pharmacist and author. He is best known for his research in the field of pharmacognosy, the study of medicines derived from natural sources, and for his novel Etidorhpa.

Early life and education[edit]

Lloyd was born in West Bloomfield, New York to Nelson Marvin Lloyd and Sophia Webster. He moved to Cincinnati, Ohio at the age of 14, where he began working as an apprentice in a pharmacy. He later attended the Cincinnati College of Pharmacy, where he graduated in 1870.

Career[edit]

After graduation, Lloyd worked as a pharmacist and conducted research in pharmacognosy. He made significant contributions to the field, particularly in the study of alkaloids, a class of naturally occurring organic compounds that mostly contain basic nitrogen atoms. His work led to the development of new methods for the extraction and purification of alkaloids.

In addition to his work in pharmacy, Lloyd was also a prolific author. His most famous work is the novel Etidorhpa, which was published in 1895. The novel is a science fiction account of a journey to the center of the earth, and it has been noted for its detailed descriptions of the natural world.

Personal life[edit]

Lloyd married Emma Rutherford in 1871. They had three children: John Thomas, Florence, and Nelson Marvin. Lloyd was a member of the American Pharmaceutical Association and the American Association for the Advancement of Science.

Legacy[edit]

Lloyd's contributions to the field of pharmacognosy have had a lasting impact. His methods for the extraction and purification of alkaloids are still used today. His novel Etidorhpa has also remained popular and has been reprinted several times.

See also[edit]

References[edit]


External links[edit]

  • John Uri Lloyd website
This article is a stub related to pharmacology. You can help WikiMD by expanding it!



Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.